Kristine Fjellanger

Ms. Kristine Fjellanger

Haukeland University Hospital
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 August 2023 in Acta Oncologica
Verified
Journal Article
Open access
Kristine FjellangerKristine Fjellanger
Kristine Fjellanger
MHMarte Hordnes
Marte Hordnes
ISInger Marie Sandvik
Inger Marie Sandvik
TSTurid Husevåg Sulen
Turid Husevåg Sulen
BHBen J. M. Heijmen
Ben J. M. Heijmen
LHLiv Bolstad Hysing
Liv Bolstad Hysing
Knowledge-based planning (KBP) is a method for automated radiotherapy treatment planning where appropriate optimization objectives for new patients are predicted based on a library of training plans. KBP can save time and improve organ at-risk sparing and inter-patient consistency compared to manual planning, but its performance depends on the quality of the training plans. We used another system for automated planning, which generates multi-criteria optimized (MCO) plans based on a wish list, to create training plans for the KBP model, to allow seamless integration of knowledge from a new system into clinical routine. Model performance was compared for KBP models trained with manually created and automatic MCO treatment plans. Two RapidPlan models with the same 30 locally advanced non-small cell lung cancer patients included were created, one containing manually created clinical plans (RP_CLIN) and one containing fully automatic multi-criteria optimized plans (RP_MCO). For 15 validation patients, model performance was compared in terms of dose-volume parameters and normal tissue complication probabilities, and an oncologist performed a blind comparison of the clinical (CLIN), RP_CLIN, and RP_MCO plans. The heart and esophagus doses were lower for RP_MCO compared to RP_CLIN, resulting in an average reduction in the risk of 2-year mortality by 0.9 percentage points and the risk of acute esophageal toxicity by 1.6 percentage points with RP_MCO. The oncologist preferred the RP_MCO plan for 8 patients and the CLIN plan for 7 patients, while the RP_CLIN plan was not preferred for any patients. RP_MCO improved OAR sparing compared to RP_CLIN and was selected for implementation in the clinic. Training a KBP model with clinical plans may lead to suboptimal output plans, and making an extra effort to optimize the library plans in the KBP model creation phase can improve the plan quality for many future patients.

13 November 2021 in Cancers
Verified
Journal Article
Open access
PDF file
Kristine FjellangerKristine Fjellanger
Kristine Fjellanger
LHLiv Bolstad Hysing
Liv Bolstad Hysing
BHBen J. M. Heijmen
Ben J. M. Heijmen
Helge Egil Seime PettersenHelge Egil Seime Pettersen
Helge Egil Seime Pettersen
ISInger Marie Sandvik
Inger Marie Sandvik
LRLinda Rossi
Linda Rossi
In this study, the novel iCE radiotherapy treatment planning system (TPS) for automated multi-criterial planning with integrated beam angle optimization (BAO) was developed, and applied to optimize organ at risk (OAR) sparing and systematically investigate the impact of beam angles on radiotherapy dose in locally advanced non-small cell lung cancer (LA-NSCLC). iCE consists of an in-house, sophisticated multi-criterial optimizer with integrated BAO, coupled to a broadly used commercial TPS. The in-house optimizer performs fluence map optimization to automatically generate an intensity-modulated radiotherapy (IMRT) plan with optimal beam angles for each patient. The obtained angles and dose-volume histograms are then used to automatically generate the final deliverable plan with the commercial TPS. For the majority of 26 LA-NSCLC patients, iCE achieved improved heart and esophagus sparing compared to the manually created clinical plans, with significant reductions in the median heart Dmean (8.1 vs. 9.0 Gy, p = 0.02) and esophagus Dmean (18.5 vs. 20.3 Gy, p = 0.02), and reductions of up to 6.7 Gy and 5.8 Gy for individual patients. iCE was superior to automated planning using manually selected beam angles. Differences in the OAR doses of iCE plans with 6 beams compared to 4 and 8 beams were statistically significant overall, but highly patient-specific. In conclusion, automated planning with integrated BAO can further enhance and individualize radiotherapy for LA-NSCLC.

8 October 2020 in Acta Oncologica
Verified
Journal Article
Closed access
JHJohanna Austrheim Hundvin
Johanna Austrheim Hundvin
Kristine FjellangerKristine Fjellanger
Kristine Fjellanger
Helge Egil Seime PettersenHelge Egil Seime Pettersen
Helge Egil Seime Pettersen
BNBritt Nygaard
Britt Nygaard
KRKari Revheim
Kari Revheim
LHLiv Bolstad Hysing
Liv Bolstad Hysing
Manual volumetric modulated arc therapy (VMAT) treatment planning for high-risk prostate cancer receiving whole pelvic radiotherapy (WPRT) with four integrated dose levels is complex and time consu...

8 March 2022 in Cancers
Verified
Journal Article
Open access
PDF file
CBCamilla Grindeland Boer
Camilla Grindeland Boer
Kristine FjellangerKristine Fjellanger
Kristine Fjellanger
ISInger Marie Sandvik
Inger Marie Sandvik
MUMaren Ugland
Maren Ugland
GEGrete May Engeseth
Grete May Engeseth
LHLiv Bolstad Hysing
Liv Bolstad Hysing
Enhancing treatment of locally advanced non-small cell lung cancer (LA-NSCLC) by using pencil beam scanning proton therapy (PBS-PT) is attractive, but little knowledge exists on the effects of uncertainties occurring between the planning (Plan) and the start of treatment (Start). In this prospective simulation study, we investigated the clinical potential for PBS-PT under the influence of such uncertainties. Imaging with 4DCT at Plan and Start was carried out for 15 patients that received state-of-the-art intensity-modulated radiotherapy (IMRT). Three PBS-PT plans were created per patient: 3D robust single-field uniform dose (SFUD), 3D robust intensity-modulated proton therapy (IMPT), and 4D robust IMPT (4DIMPT). These were exposed to setup and range uncertainties and breathing motion at Plan, and changes in breathing motion and anatomy at Start. Target coverage and dose-volume parameters relevant for toxicity were compared. The organ at risk sparing at Plan was greatest with IMPT, followed by 4DIMPT, SFUD and IMRT, and persisted at Start. All plans met the preset criteria for target robustness at Plan. At Start, three patients had a lack of CTV coverage with PBS-PT. In conclusion, the clinical potential for heart and lung toxicity reduction with PBS-PT was substantial and persistent. Altered breathing patterns between Plan and Start jeopardized target coverage for all PBS-PT techniques.

16 May 2024 in Physics and Imaging in Radiation Oncology
Verified
Journal Article
Open access
Kristine FjellangerKristine Fjellanger
Kristine Fjellanger
BHBen J.M. Heijmen
Ben J.M. Heijmen
SBSebastiaan Breedveld
Sebastiaan Breedveld
ISInger Marie Sandvik
Inger Marie Sandvik
LHLiv B. Hysing
Liv B. Hysing
Background and purpose: For locally advanced non-small cell lung cancer (LA-NSCLC), intensity-modulated proton therapy (IMPT) can reduce organ at risk (OAR) doses compared to intensity-modulated radiotherapy (IMRT). Deep inspiration breath hold (DIBH) reduces OAR doses compared to free breathing (FB) in IMRT. In IMPT, differences in dose distributions and robustness between DIBH and FB are unclear. In this study, we compare DIBH to FB in IMPT, and IMPT to IMRT. Materials and methods: Fortyone LA-NSCLC patients were prospectively included. 4D computed tomography images (4DCTs) and DIBH CTs were acquired for treatment planning and during weeks 1 and 3 of treatment. A new system for automated robust planning was developed and used to generate a FB and a DIBH IMPT plan for each patient. Plans were compared in terms of dose-volume parameters and normal tissue complication probabilities (NTCPs). Dose recalculations on repeat CTs were used to compare inter-fraction plan robustness. Results: In IMPT, DIBH reduced median lungs D-mean from 9.3 Gy(RBE) to 8.0 Gy(RBE) compared to FB, and radiation pneumonitis NTCP from 10.9 % to 9.4 % (p < 0.001). Inter-fraction plan robustness for DIBH and FB was similar. Median NTCPs for radiation pneumonitis and mortality were around 9 percentage points lower with IMPT than IMRT (p < 0.001). These differences were much larger than between FB and DIBH within each modality. Conclusion: DIBH IMPT resulted in reduced lung dose and radiation pneumonitis NTCP compared to FB IMPT. Inter-fraction robustness was comparable. OAR doses were far lower in IMPT than IMRT.

27 May 2026 in Acta Oncologica
Verified
Journal Article
Open access
ICIngvild Helø Carlsen
Ingvild Helø Carlsen
VDVilde Ragnvaldsen Dyvik
Vilde Ragnvaldsen Dyvik
TJTuva Borgund Johannessen
Tuva Borgund Johannessen
Kristine FjellangerKristine Fjellanger
Kristine Fjellanger
ISInger Marie Sandvik
Inger Marie Sandvik
LHLiv Bolstad Hysing
Liv Bolstad Hysing
Background and purpose: Locoregional tumor control is strongly associated with survival for non-small cell lung cancer, emphasizing the importance of precise radiotherapy delivery. This study aims to evaluate a traffic light adaptation protocol regarding target coverage, protocol performance and patient outcomes.Material and methods: From 2019 to 2022, we prospectively enrolled inoperable non-small cell lung cancer patients. We acquired daily cone-beam computed tomography and traffic light registrations, classifying anatomical changes and need of action. Using repeated computed tomography (rCT) in week 1 and 3 for dosimetric evaluation, we recalculated clinical target volume (CTV) D98% and V95% with and without adaptation, and compared traffic light registrations with the actual dose distribution. Protocol performance was evaluated by the sensitivity and specificity in detecting CTV V95% < 98%.Results: Among 45 patients with complete registrations, baseline shift and tumor shrinkage were most common changes, leading to corrections from bone to tumor match in 37.8% and replanning in 13.3% of patients. Among 38 patients with at least one rCT, 15.8% would have received insufficient CTV coverage without adaptation. Protocol sensitivity, specificity and balanced accuracy were 83.3, 88.6, and 85.7%, respectively. For 38 stage II–III patients, median overall survival was 43.5 months (95% confidence interval [CI]: 32.9–54.1), median time to locoregional failure 27.4 months (95% CI: 0–61.8) and median estimated time to distant failure 30.7 months (CI not estimated due to censoring).Interpretation: The protocol identified relevant changes, improving target coverage without increasing organ at risk doses. With appropriate training, protocol performance was good, and clinical outcomes were consistent with international results.